Literature DB >> 26580894

Cellulitis and erysipelas: prevention.

Choon Chiat Oh1.   

Abstract

INTRODUCTION: Cellulitis is a common problem caused by spreading bacterial inflammation of the skin, with redness, pain, and lymphangitis. Up to 40% of affected people have systemic illness. Erysipelas is a form of cellulitis with marked superficial inflammation, typically affecting the lower limbs and the face. The most common pathogens in adults are streptococci and Staphylococcus aureus. Cellulitis and erysipelas can result in local necrosis and abscess formation. Around one quarter of affected people have more than one episode of cellulitis within 3 years. METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical question: What are the effects of treatments to prevent recurrence of cellulitis and erysipelas? We searched: Medline, Embase, The Cochrane Library, and other important databases up to February 2015 (Clinical Evidence overviews are updated periodically; please check our website for the most up-to-date version of this overview).
RESULTS: At this update, searching of electronic databases retrieved 323 studies. After deduplication and removal of conference abstracts, 184 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 170 studies and the further review of 14 full publications. Of the 14 full articles evaluated, one systematic review was added at this update. We performed a GRADE evaluation for one PICO combination.
CONCLUSIONS: In this systematic overview, we categorised the efficacy for two interventions based on information about to the effectiveness and safety of antibiotics and treatment of predisposing factors.

Entities:  

Year:  2015        PMID: 26580894      PMCID: PMC4651026     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  11 in total

1.  Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections.

Authors:  M Kremer; R Zuckerman; Z Avraham; R Raz
Journal:  J Infect       Date:  1991-01       Impact factor: 6.072

2.  Why have group A streptococci remained susceptible to penicillin? Report on a symposium.

Authors:  D L Horn; J B Zabriskie; R Austrian; P P Cleary; J J Ferretti; V A Fischetti; E Gotschlich; E L Kaplan; M McCarty; S M Opal; R B Roberts; A Tomasz; Y Wachtfogel
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

3.  Recurrent erysipelas: predisposing factors and costs of prophylaxis.

Authors:  C Jorup-Rönström; S Britton
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

Review 4.  Antibiotic prophylaxis for preventing recurrent cellulitis: a systematic review and meta-analysis.

Authors:  Choon Chiat Oh; Henry Chung Hung Ko; Haur Yueh Lee; Nasia Safdar; Dennis G Maki; Maciej Piotr Chlebicki
Journal:  J Infect       Date:  2014-02-24       Impact factor: 6.072

5.  Cellulitis Recurrence Score: a tool for predicting recurrence of lower limb cellulitis.

Authors:  Evelyn Yuxin Tay; Stephanie Fook-Chong; Choon Chiat Oh; Thamotharampillai Thirumoorthy; Shiu Ming Pang; Haur Yueh Lee
Journal:  J Am Acad Dermatol       Date:  2014-10-16       Impact factor: 11.527

6.  Case survey of management of cellulitis in a tertiary teaching hospital.

Authors:  A A Aly; N M Roberts; K S Seipol; D G MacLellan
Journal:  Med J Aust       Date:  1996-11-18       Impact factor: 7.738

7.  Penicillin to prevent recurrent leg cellulitis.

Authors:  Kim S Thomas; Angela M Crook; Andrew J Nunn; Katharine A Foster; James M Mason; Joanne R Chalmers; Ibrahim S Nasr; Richard J Brindle; John English; Sarah K Meredith; Nicholas J Reynolds; David de Berker; Peter S Mortimer; Hywel C Williams
Journal:  N Engl J Med       Date:  2013-05-02       Impact factor: 91.245

8.  Antibiotic prophylaxis in recurrent erysipelas.

Authors:  A C Sjöblom; B Eriksson; C Jorup-Rönström; K Karkkonen; M Lindqvist
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

9.  Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique.

Authors:  P Bernard; C Bedane; M Mounier; F Denis; G Catanzano; J M Bonnetblanc
Journal:  Arch Dermatol       Date:  1989-06

10.  Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial.

Authors:  Kim Thomas; Angela Crook; Katharine Foster; James Mason; Joanne Chalmers; John Bourke; Adam Ferguson; Nick Level; Andrew Nunn; Hywel Williams
Journal:  Br J Dermatol       Date:  2011-12-06       Impact factor: 9.302

View more
  1 in total

Review 1.  Patient-Reported Outcome Measures With Secondary Lower Limb Lymphedemas: A Systematic Review.

Authors:  Margit Eidenberger
Journal:  J Adv Pract Oncol       Date:  2021-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.